NO141314C - Analogifremgangsmaate ved fremstilling av det terapeutisk aktive n-(1`-allylpyrrolidinyl-2`-methyl)-2-methoxy-4,5-azimidobenzamid - Google Patents

Analogifremgangsmaate ved fremstilling av det terapeutisk aktive n-(1`-allylpyrrolidinyl-2`-methyl)-2-methoxy-4,5-azimidobenzamid

Info

Publication number
NO141314C
NO141314C NO750759A NO750759A NO141314C NO 141314 C NO141314 C NO 141314C NO 750759 A NO750759 A NO 750759A NO 750759 A NO750759 A NO 750759A NO 141314 C NO141314 C NO 141314C
Authority
NO
Norway
Prior art keywords
allylpyrrolidinyl
azimidobenzamide
methoxy
methyl
preparation
Prior art date
Application number
NO750759A
Other languages
English (en)
Other versions
NO141314B (no
NO750759L (no
Inventor
Gerard Bulteau
Jacques Acher
Claude Collignon
Jean-Claude Monier
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19752500919 external-priority patent/DE2500919C3/de
Application filed by Ile De France filed Critical Ile De France
Publication of NO750759L publication Critical patent/NO750759L/no
Publication of NO141314B publication Critical patent/NO141314B/no
Publication of NO141314C publication Critical patent/NO141314C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO750759A 1975-01-11 1975-03-07 Analogifremgangsmaate ved fremstilling av det terapeutisk aktive n-(1`-allylpyrrolidinyl-2`-methyl)-2-methoxy-4,5-azimidobenzamid NO141314C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752500919 DE2500919C3 (de) 1975-01-11 5-(l-Allyl-2-pyrrolidinylmethylaminocarbonyl)-6-methoxy-benzotriazol sowie seine pharmazeutisch verträglichen Additionssalze mit Säuren

Publications (3)

Publication Number Publication Date
NO750759L NO750759L (no) 1976-07-13
NO141314B NO141314B (no) 1979-11-05
NO141314C true NO141314C (no) 1980-02-13

Family

ID=5936259

Family Applications (1)

Application Number Title Priority Date Filing Date
NO750759A NO141314C (no) 1975-01-11 1975-03-07 Analogifremgangsmaate ved fremstilling av det terapeutisk aktive n-(1`-allylpyrrolidinyl-2`-methyl)-2-methoxy-4,5-azimidobenzamid

Country Status (30)

Country Link
JP (1) JPS5616793B2 (no)
AR (2) AR211237A1 (no)
AT (1) AT358568B (no)
BE (1) BE825605A (no)
CA (1) CA1036608A (no)
CH (1) CH601290A5 (no)
CS (1) CS219314B2 (no)
CY (1) CY975A (no)
DD (1) DD117677A5 (no)
DK (1) DK138391C (no)
EG (1) EG11931A (no)
FI (1) FI57103C (no)
FR (1) FR2297041A1 (no)
GB (1) GB1475234A (no)
HK (1) HK14178A (no)
HU (1) HU170638B (no)
IE (1) IE41349B1 (no)
IL (1) IL46622A (no)
LU (1) LU72000A1 (no)
MW (1) MW975A1 (no)
NL (1) NL161985C (no)
NO (1) NO141314C (no)
OA (1) OA04965A (no)
PL (1) PL95772B1 (no)
RO (3) RO78909A (no)
SE (1) SE404698B (no)
SU (1) SU577990A3 (no)
YU (1) YU40434B (no)
ZA (1) ZA75903B (no)
ZM (1) ZM2875A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6084609U (ja) * 1983-11-17 1985-06-11 アサヒ住宅株式会社 床下換気口
JPS6111804U (ja) * 1984-06-06 1986-01-23 フクビ化学工業株式会社 床下換気装置
DE19654038A1 (de) * 1996-12-23 1998-06-25 Basf Ag Verfahren zur Herstellung von alpha-Tocopherol oder alpha-Tocopherylacetat durch Umsetzen von Trimethylhydrochinon und Phytol oder Isophytol unter Rückführung des Kondensationskatalysators Zinkchlorid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6787M (no) * 1967-08-17 1969-03-17

Also Published As

Publication number Publication date
NL161985C (nl) 1980-04-15
SU577990A3 (ru) 1977-10-25
IL46622A0 (en) 1975-04-25
EG11931A (en) 1978-09-30
ZA75903B (en) 1976-03-31
JPS5180858A (no) 1976-07-15
AT358568B (de) 1980-09-25
LU72000A1 (no) 1976-02-04
NO141314B (no) 1979-11-05
CS219314B2 (en) 1983-03-25
IE41349L (en) 1976-07-11
FR2297041B1 (no) 1978-08-04
HU170638B (no) 1977-07-28
DK92375A (da) 1976-07-12
AR212635A1 (es) 1978-08-31
CH601290A5 (no) 1978-07-14
DE2500919B2 (de) 1977-06-08
RO72712A (ro) 1981-04-20
DE2500919A1 (de) 1976-07-15
AR211237A1 (es) 1977-11-15
IL46622A (en) 1979-01-31
IE41349B1 (en) 1979-12-19
CY975A (en) 1978-12-22
AU7868775A (en) 1976-09-02
JPS5616793B2 (no) 1981-04-18
YU51875A (en) 1982-06-30
OA04965A (fr) 1980-10-31
HK14178A (en) 1978-03-23
FI750525A (no) 1976-07-12
FR2297041A1 (fr) 1976-08-06
PL95772B1 (pl) 1977-11-30
SE404698B (sv) 1978-10-23
RO79040A (ro) 1982-06-25
ATA160475A (de) 1980-02-15
NL161985B (nl) 1979-11-15
SE7502343L (sv) 1976-07-12
GB1475234A (en) 1977-06-01
YU40434B (en) 1986-02-28
DK138391B (da) 1978-08-28
BE825605A (fr) 1975-08-18
FI57103C (fi) 1980-06-10
NL7502831A (nl) 1976-07-13
NO750759L (no) 1976-07-13
ZM2875A1 (en) 1975-12-22
CA1036608A (en) 1978-08-15
FI57103B (fi) 1980-02-29
DD117677A5 (no) 1976-01-20
RO78909A (ro) 1982-04-12
DK138391C (da) 1979-03-12
MW975A1 (en) 1976-04-14

Similar Documents

Publication Publication Date Title
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO152215C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
NO157817C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glycinamidderivater.
NO153135C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme n-(fenoksyalkyl)-imidazolderivater.
NO142304C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1-a)-isokinolin-derivater
NO145379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider.
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO145791C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater
NO149999C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme n-(4-acyloksyfenyl)-all-trans-retinamider.
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
NO147150C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperidiner.
NO144108C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider
NO145793C (no) Analogifremgangsmaate for fremstilling av den fysiologisk aktive forbindelse n-(r-tetrahydrofurfuryl)-noroksymorfon
NO144457C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO150158C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater
NO145620C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive depotsteroidestere.
NO144110C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
NO144741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler